Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Deferred Revenue: 2012-2025

Historic Current Deferred Revenue for Veracyte (VCYT) over the last 7 years, with Sep 2025 value amounting to $417,000.

  • Veracyte's Current Deferred Revenue fell 79.49% to $417,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $417,000, marking a year-over-year decrease of 79.49%. This contributed to the annual value of $1.7 million for FY2024, which is 16.68% down from last year.
  • Veracyte's Current Deferred Revenue amounted to $417,000 in Q3 2025, which was down 71.24% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Current Deferred Revenue registered a high of $4.9 million during Q1 2022, and its lowest value of $417,000 during Q3 2025.
  • Its 3-year average for Current Deferred Revenue is $1.9 million, with a median of $2.0 million in 2024.
  • As far as peak fluctuations go, Veracyte's Current Deferred Revenue soared by 1,152.29% in 2021, and later tumbled by 79.49% in 2025.
  • Quarterly analysis of 5 years shows Veracyte's Current Deferred Revenue stood at $4.6 million in 2021, then tumbled by 43.76% to $2.6 million in 2022, then declined by 23.15% to $2.0 million in 2023, then declined by 16.68% to $1.7 million in 2024, then plummeted by 79.49% to $417,000 in 2025.
  • Its last three reported values are $417,000 in Q3 2025, $1.4 million for Q2 2025, and $1.7 million during Q1 2025.